You are here

Cortexyme

Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity

Pfizer, Verily-backed Alzheimer's biotech Cortexyme hit by FDA partial hold over liver toxicity

Fierce Biotech

Alzheimer's disease

Flag link:

Alzheimer’s catalysts round off a year dominated by Biogen

Alzheimer’s catalysts round off a year dominated by Biogen

EP Vantage

Alzheimer's disease

Flag link:

Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch

Four biotech Nasdaq wannabes outline IPO plans — and don't miss Chi-Med's HKEX pitch

Endpoints

Applied Therapeutics

Milestone Pharmaceuticals

Flag link:

Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO

Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO

CP Wire

Alzheimer's disease

Flag link:

Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO

Alzheimer's disease

Flag link:

4 Companies Pfizer Just Increased Its Stake In

4 Companies Pfizer Just Increased Its Stake In

Yahoo/Benzinga

4D Molecular Therapeutics

Flag link: